| 000 | 01160 am a22002293u 4500 | ||
|---|---|---|---|
| 042 | _adc | ||
| 100 | 1 | 0 |
_aBurry, Jessica _eauthor _92983 |
| 700 | 1 | 0 |
_aCasas, Carmen Perez _eauthor _92984 |
| 700 | 1 | 0 |
_aFord, Nathan _eauthor _92985 |
| 245 | 0 | 0 | _aAccess to medicines for treating people with cryptococcal meningitis |
| 260 | _c2023-02-08. | ||
| 500 | _a/pmc/articles/PMC7614173/ | ||
| 500 | _a/pubmed/36037037 | ||
| 520 | _aCryptococcal meningitis accounts for one in five AIDS-related deaths globally. WHO guidelines strongly recommend a single high-dose of liposomal amphotericin B as part of preferred treatment, but this drug remains unaffordable in most low- and middle-income countries. A proactive approach is needed from manufacturers and other stakeholders to improve access. | ||
| 540 | _a | ||
| 540 | _ahttps://creativecommons.org/licenses/by/4.0/This work is licensed under a CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/) International license. | ||
| 546 | _aen | ||
| 690 | _aArticle | ||
| 655 | 7 |
_aText _2local |
|
| 786 | 0 | _nClin Infect Dis | |
| 856 | 4 | 1 |
_uhttp://dx.doi.org/10.1093/cid/ciac689/6678599 _zConnect to this object online. |
| 999 |
_c2392 _d2392 |
||